Non‐T‐Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP / EBMT
American Journal of Hematology · 2026
DOI: 10.1002/ajh.70164 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift American Journal of Hematology, 2026. Verfasst von Arnon Nagler und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Unrelated Donors, Hematopoietic Stem Cell Transplantation, Transplantation, Haploidentical. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative option for secondary acute myeloid leukemia (sAML). This study compared haploidentical donor (Haplo), matched sibling donor (MSD), and matched unrelated donor (MUD) HSCT in patients with sAML in first complete remission (CR1). Data from 3862 patients (Haplo = 643, MSD = 715, MUD = 2504) transplanted between 2010 and 2022 were analyzed, with a median follow‐up of 3.3 years. Groups differed in patient and donor age, conditioning regimen, stem cell source, and graft‐versus‐host disease (GVHD) prophylaxis. Multivariate analysis showed that MSD‐HSCT had a higher relapse risk than Haplo‐HSCT (hazard ratio [HR]: 1.64) but lower non‐relapse mortality (NRM, HR: 0.32) and acute GVHD risk (HR: 0.54 for grade II–IV), leading to an overall survival (OS) benefit (HR: 0.76). MUD‐HSCT had lower NRM than Haplo‐HSCT (HR: 0.63) but there were no significant differences in OS or GVHD risk. Donor type did not impact leukemia‐free survival (LFS) or GVHD‐free and relapse‐free survival (GRFS). Adverse cytogenetics and reduced‐intensity conditioning were associated with increased relapse risk, while lower Karnofsky scores, older age, and adverse cytogenetics independently predicted worse NRM, LFS, OS, and GRFS outcomes. Female‐to‐male donor‐recipient pairs had an increased risk of chronic GVHD. In this registry‐based analysis, MSD offered the best outcomes for sAML in CR1. Haplo‐HSCT was comparable to MUD‐HSCT, despite a higher NRM, and achieved long‐term disease control in 60% of patients due to a low relapse incidence. In the absence of an MSD, both Haplo and MUD are viable alternatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel.
- Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
- EBMT Paris Study Office; Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France.
- University Hospital Eppendorf, Hamburg, Germany.
- Hannover Medical School, Hannover, Germany.
- Saint-Louis Hospital, BMT Unit, Paris, France.
ORCID-Profile: Arnon Nagler, Sarah Kayser, Alessandro Rambaldi, Gesine Bug, Ali Bazarbachi
Zitieren
APA
Nagler, A., Kayser, S., Ferhat, A. T., Kröger, N., Eder, M., Socié, G., Blaise, D., Schroeder, T., Labussière-Wallet, H., Maertens, J., Busca, A., Forcade, E., Gedde-Dahl, T., Rambaldi, A., Bulabois, C. E., Bug, G., Bazarbachi, A., Brissot, E., Savani, B., …, & Ciceri, F. (2026). Non‐T‐Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP / EBMT. American Journal of Hematology. https://doi.org/10.1002/ajh.70164
Vancouver
Nagler A, Kayser S, Ferhat AT, Kröger N, Eder M, Socié G, et al. Non‐T‐Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP / EBMT. American Journal of Hematology. 2026. doi:10.1002/ajh.70164
BibTeX
@article{Nagler2026,
author = {Nagler, Arnon and Kayser, Sarah and Ferhat, Allain Thibeault and Kröger, Nicolaus and Eder, Matthias and Socié, Gérard and Blaise, Didier and Schroeder, Thomas and Labussière-Wallet, Hélène and Maertens, Johan and Busca, Alessandro and Forcade, Edouard and Gedde-Dahl, Tobias and Rambaldi, Alessandro and Bulabois, Claude Eric and Bug, Gesine and Bazarbachi, Ali and Brissot, Eolia and Savani, Bipin and Mohty, Mohamad and Ciceri, Fabio},
title = {Non‐T‐Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP / EBMT},
journal = {American Journal of Hematology},
year = {2026},
doi = {10.1002/ajh.70164}
}
EUVIMED